Office: 303 Baum, 3B- 3

Email: Richard.Bertz@pitt.edu

Richard (Rick) Bertz, PhD joined the University of Pittsburgh from Pharmaceutical Industry in 2018, and is currently a Professor, Pharmaceutical Sciences and Associate Dean, PharmacoAnalytics. Dr. Bertz is working with faculty, staff, and students to develop a PharmacoAnalytics program that includes computational drug discovery, pharmacometrics and systems pharmacology, pharmacoeconomics and outcomes, and patient safety. He seeks new ways to develop successful industry partnerships that will benefit faculty and students of various degree programs. Dr. Bertz worked in pharmaceutical industry for 22 years, most recently as Vice President and Head, Clinical Pharmacology and Pharmacometrics at Bristol-Myers Squibb, responsible for facilitating decision making and driving strategy, overseeing a group of PharmD, MS, MD and PhD scientists. He also built and led a group of quantitative systems pharmacologists.

Dr. Bertz received a BS in Pharmacy from the University of Wisconsin and earned his PhD in Pharmacokinetics/Pharmacodynamics from the University of Pittsburgh Clinical Pharmaceutical Scientist Graduate Program. During his career in pharmaceutical industry, which began at Abbott Laboratories, Dr. Bertz has been involved in all phases of clinical drug development, with a focus on the analysis and interpretation of clinical pharmacology and pharmacometric data. During his career, Dr. Bertz has mentored, coached, managed and developed numerous clinical pharmacologists and drug development scientists. He has co-taught several academic and industry courses, including ten years team teaching ‘An Introduction to Drug Metabolism’ short course at the University Wisconsin Extension Services in Pharmacy. Dr. Bertz has been integrally involved in the completion of components of NDA submissions that have led to worldwide regulatory approval for three drugs, two to treat HIV and one for HCV. He and several colleagues at Abbott Labs received the Intellectual Property Law Association of Chicago Inventor of the Year Award in 2004. Dr. Bertz has a passion for developing life-saving drugs for patients that are in need.

Dr. Bertz is an active member of the American Foundation for Pharmaceutical Education (AFPE) Board of Grants, past Secretary for the IQ Industry Consortium Clinical Pharmacology Leadership Group, a member of the Rho Chi Pharmacy Honor Society, and a reviewer for several Clinical Pharmacology Journals. He is also an active member of the American Society of Clinical Pharmacology and Therapeutics, American Conference on Pharmacometrics and the American Association for Pharmaceutical Scientists. Dr. Bertz has coauthored over 70 peer-reviewed publications and given numerous invited presentations at national and international scientific meetings, as well as at universities. Dr. Bertz received the Legacy Laureate Award from the University of Pittsburgh in 2014 and a Citation of Merit from the University of Wisconsin School of Pharmacy in 2016 for recognition as a distinguished alumnus.